These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A case of sensory ataxic Guillain-Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). Fukushima T; Tomita M; Ikeda S; Hattori N QJM; 2022 Jan; 115(1):25-27. PubMed ID: 34871447 [No Abstract] [Full Text] [Related]
4. Guillain-Barré syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea. Kim N; Kim JH; Park JS Neurol Sci; 2022 Mar; 43(3):1491-1493. PubMed ID: 34981285 [No Abstract] [Full Text] [Related]
5. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination. Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134 [TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. García-Grimshaw M; Michel-Chávez A; Vera-Zertuche JM; Galnares-Olalde JA; Hernández-Vanegas LE; Figueroa-Cucurachi M; Paredes-Ceballos O; Reyes-Terán G; Carbajal-Sandoval G; Ceballos-Liceaga SE; Arauz A; Valdés-Ferrer SI Clin Immunol; 2021 Sep; 230():108818. PubMed ID: 34358692 [TBL] [Abstract][Full Text] [Related]
7. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Masuccio FG; Comi C; Solaro C Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184 [No Abstract] [Full Text] [Related]
9. [A Patient Developing Guillain-Barré Syndrome After Receiving the BNT162b2 COVID-19 mRNA Vaccine]. Oshibe N; Honda M; Koga M; Sato R; Oishi M; Kanda T Brain Nerve; 2022 Aug; 74(8):1025-1030. PubMed ID: 35941801 [TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417 [TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent. Malamud E; Otallah SI; Caress JB; Lapid DJ Pediatr Neurol; 2022 Jan; 126():9-10. PubMed ID: 34717201 [No Abstract] [Full Text] [Related]
13. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association? Introna A; Caputo F; Santoro C; Guerra T; Ucci M; Mezzapesa DM; Trojano M Clin Neurol Neurosurg; 2021 Sep; 208():106887. PubMed ID: 34418708 [TBL] [Abstract][Full Text] [Related]
14. Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome. Li HF; Hu SM; Lv M JAMA; 2022 Jan; 327(4):392-393. PubMed ID: 35076675 [No Abstract] [Full Text] [Related]
15. Guillain-Barré Syndrome Following the mRNA COVID-19 Vaccination: Comment. Mungmunpuntipantip R; Wiwanitkit V Acta Neurol Taiwan; 2023 Dec; 32(4)():228-229. PubMed ID: 37781729 [TBL] [Abstract][Full Text] [Related]
16. Before SARS-CoV-2 Vaccine is Held Responsible for Guillain-Barre Syndrome, Other Causes Must be Removed From the Table. Finsterer J J Clin Neuromuscul Dis; 2024 Mar; 25(3):146-148. PubMed ID: 38441933 [No Abstract] [Full Text] [Related]
18. Guillain-Barré syndrome after COVID-19 vaccination. McKean N; Chircop C BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729 [TBL] [Abstract][Full Text] [Related]
19. In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine. Med Lett Drugs Ther; 2021 Aug; 63(1630):121. PubMed ID: 34550109 [No Abstract] [Full Text] [Related]